Yanhua Tian

6.1k total citations · 2 hit papers
33 papers, 3.6k citations indexed

About

Yanhua Tian is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Yanhua Tian has authored 33 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Oncology and 11 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Yanhua Tian's work include Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Treatments and Mutations (5 papers) and Extracellular vesicles in disease (4 papers). Yanhua Tian is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Treatments and Mutations (5 papers) and Extracellular vesicles in disease (4 papers). Yanhua Tian collaborates with scholars based in China, United States and Australia. Yanhua Tian's co-authors include Guangjun Nie, Gregory J. Anderson, Suping Li, Tianjiao Ji, Motao Zhu, Jian Song, Jingyan Wei, Yuliang Zhao, Jing Wang and Yinlong Zhang and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Yanhua Tian

31 papers receiving 3.5k citations

Hit Papers

A doxorubicin delivery platform using engineered natural ... 2013 2026 2017 2021 2013 2018 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy
    2013 1.5k citations Yanhua Tian, Suping Li et al. Biomaterials profile →
  2. A DNA nanorobot functions as a cancer therapeutic in response to a molecular trigger in vivo
    2018 1.2k citations Suping Li, Yinlong Zhang et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanhua Tian China 17 2.7k 1.1k 996 430 410 33 3.6k
William Querbes United States 25 3.8k 1.4× 585 0.5× 644 0.6× 661 1.5× 517 1.3× 37 5.1k
In-San Kim South Korea 36 2.1k 0.8× 520 0.5× 886 0.9× 535 1.2× 967 2.4× 68 3.8k
Emilia S. Olson United States 14 1.3k 0.5× 305 0.3× 853 0.9× 308 0.7× 485 1.2× 20 2.4k
Minh T. N. Le Singapore 29 2.8k 1.1× 1.9k 1.8× 405 0.4× 261 0.6× 158 0.4× 54 3.6k
Lin Tang China 28 1.1k 0.4× 355 0.3× 1.2k 1.2× 362 0.8× 353 0.9× 72 2.5k
Kevin T. Love United States 17 3.0k 1.1× 399 0.4× 636 0.6× 167 0.4× 527 1.3× 17 3.5k
Daisy W.J. van der Schaft Netherlands 31 1.6k 0.6× 448 0.4× 695 0.7× 612 1.4× 552 1.3× 42 2.8k
Gi‐Hoon Nam South Korea 26 1.3k 0.5× 642 0.6× 696 0.7× 393 0.9× 298 0.7× 47 2.2k
Matthew J. Haney United States 18 4.2k 1.6× 2.3k 2.1× 921 0.9× 134 0.3× 477 1.2× 31 4.9k

Countries citing papers authored by Yanhua Tian

Since Specialization
Citations

This map shows the geographic impact of Yanhua Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanhua Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanhua Tian more than expected).

Fields of papers citing papers by Yanhua Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanhua Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanhua Tian. The network helps show where Yanhua Tian may publish in the future.

Co-authorship network of co-authors of Yanhua Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Yanhua Tian. A scholar is included among the top collaborators of Yanhua Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanhua Tian. Yanhua Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
3.
Wang, Yalong, Zhenlin Yang, Ping Chen, et al.. (2023). Genetic trajectory and clonal evolution of multiple primary lung cancer with lymph node metastasis. Cancer Gene Therapy. 2 indexed citations
4.
Tian, Yanhua, et al.. (2023). PHACTR1 promotes the mobility of papillary thyroid carcinoma cells by inducing F-actin formation. Heliyon. 9(10). e20461–e20461.
5.
6.
Tian, Yanhua, et al.. (2023). ZEB1 Is Regulated by K811 Acetylation to Promote Stability, NuRD Complex Interactions, EMT, and NSCLC Metastasis. Molecular Cancer Research. 21(8). 779–794. 5 indexed citations
7.
Tian, Yanhua, et al.. (2023). Pseudoginsenoside GQ mitigates chronic intermittent hypoxia-induced cognitive damage by modulating microglia polarization. International Immunopharmacology. 126. 111234–111234. 6 indexed citations
8.
Yang, Zhenlin, Jiachen Xu, Lin Li, et al.. (2020). Integrated molecular characterization reveals potential therapeutic strategies for pulmonary sarcomatoid carcinoma. Nature Communications. 11(1). 4878–4878. 42 indexed citations
9.
Tian, Yanhua, Jiachen Xu, Qian Chu, et al.. (2020). A novel tumor mutational burden estimation model as a predictive and prognostic biomarker in NSCLC patients. BMC Medicine. 18(1). 232–232. 22 indexed citations
10.
Han, Jiefei, Jianchun Duan, Hua Bai, et al.. (2019). TCR Repertoire Diversity of Peripheral PD-1+CD8+ T Cells Predicts Clinical Outcomes after Immunotherapy in Patients with Non–Small Cell Lung Cancer. Cancer Immunology Research. 8(1). 146–154. 177 indexed citations
11.
Yu, Jiangyong, Shuhang Wang, Wei Zhao, et al.. (2018). Mechanistic Exploration of Cancer Stem Cell Marker Voltage-Dependent Calcium Channel α2δ1 Subunit-mediated Chemotherapy Resistance in Small-Cell Lung Cancer. Clinical Cancer Research. 24(9). 2148–2158. 47 indexed citations
12.
Tian, Yanhua, Zhijie Wang, Xiaohui Liu, et al.. (2018). Prediction of Chemotherapeutic Efficacy in Non–Small Cell Lung Cancer by Serum Metabolomic Profiling. Clinical Cancer Research. 24(9). 2100–2109. 57 indexed citations
13.
Liu, Yang, Yanhua Tian, Wei Sun Leong, et al.. (2018). Efficient and tumor-specific knockdown of MTDH gene attenuates paclitaxel resistance of breast cancer cells both in vivo and in vitro. Breast Cancer Research. 20(1). 113–113. 37 indexed citations
14.
Tian, Yanhua, Hua Bai, Jin Wang, & Jie Wang. (2017). PUB146 Prognostic Prediction of Pemetrexed-Platinum Chemotherapeutic Regimen by Serum Metabolomics. Journal of Thoracic Oncology. 12(1). S1530–S1531. 1 indexed citations
15.
Li, Suping, Yanhua Tian, Ying Zhao, et al.. (2015). pHLIP-mediated targeting of truncated tissue factor to tumor vessels causes vascular occlusion and impairs tumor growth. Oncotarget. 6(27). 23523–23532. 30 indexed citations
16.
Ji, Tianjiao, Ying Zhao, Ying Zhao, et al.. (2013). Tumor Fibroblast Specific Activation of a Hybrid Ferritin Nanocage‐Based Optical Probe for Tumor Microenvironment Imaging. Small. 9(14). 2427–2431. 47 indexed citations
17.
Tian, Yanhua, Suping Li, Jian Song, et al.. (2013). A doxorubicin delivery platform using engineered natural membrane vesicle exosomes for targeted tumor therapy. Biomaterials. 35(7). 2383–2390. 1476 indexed citations breakdown →
18.
Zhu, Motao, Xin Tian, Yiye Li, et al.. (2012). Nanoparticle‐Induced Exosomes Target Antigen‐Presenting Cells to Initiate Th1‐Type Immune Activation. Small. 8(18). 2841–2848. 77 indexed citations
19.
Tian, Xin, Motao Zhu, Yanhua Tian, et al.. (2012). A membrane vesicle-based dual vaccine against melanoma and Lewis lung carcinoma. Biomaterials. 33(26). 6147–6154. 40 indexed citations
20.
Wu, San‐Gang, Taixing Cui, Chong Zhao, et al.. (2008). A Randomized Controlled Multicenter Trial of Actovegin Against Acute Oral Mucositis Induced by Chemo-radiotherapy for Nasopharyngeal Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 72(1). S380–S381. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by William Querbes Breakdown of academic impact, for papers by In-San Kim Breakdown of academic impact, for papers by Emilia S. Olson Breakdown of academic impact, for papers by Minh T. N. Le Breakdown of academic impact, for papers by Lin Tang Breakdown of academic impact, for papers by Kevin T. Love Breakdown of academic impact, for papers by Daisy W.J. van der Schaft Breakdown of academic impact, for papers by Gi‐Hoon Nam Breakdown of academic impact, for papers by Matthew J. Haney
Rankless by CCL
2026